Adagene (ADAG) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $2.06, -14.17% vs the prior close of $2.40.
- Volume 379.60K shares, 1.2x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ADAG slides 14.2% to $2.06, a 6-month low. Closed at $2.06, -14.17% vs the prior close of $2.40. Day range $2.01–$2.40, opened at $2.40.
ADAG daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — ADAG slides 14.2% to $2.06, a 6-month low
- Closed at $2.06, -14.17% vs the prior close of $2.40. Day range $2.01–$2.40, opened at $2.40.
- Volume was 379.60K shares, 1.2x its 50-day average of 304.73K.
- Price is -38.3% vs its 50-day average ($3.34) and -39.2% vs its 200-day average ($3.39).
- 52-week range $1.30–$4.85; today's close sits at 21% of that range, 57.5% below the 52-week high.
Oct 15, 2026 — ADAG jumps 4.8% to $2.40 on 1.8x normal volume
- Closed at $2.40, +4.80% vs the prior close of $2.29. Day range $2.26–$2.42, opened at $2.31.
- Volume was 552.50K shares, 1.8x its 50-day average of 302.39K — unusually heavy trading.
- Price is -29.0% vs its 50-day average ($3.38) and -29.1% vs its 200-day average ($3.38).
- 52-week range $1.30–$4.85; today's close sits at 31% of that range, 50.5% below the 52-week high.
Oct 14, 2026 — ADAG slides 6.9% to $2.29, a 6-month low on 3.1x normal volume
- Closed at $2.29, -6.91% vs the prior close of $2.46. Day range $2.25–$2.50, opened at $2.35.
- Volume was 898.90K shares, 3.1x its 50-day average of 286.68K — unusually heavy trading.
- Price is -33.0% vs its 50-day average ($3.42) and -32.3% vs its 200-day average ($3.38).
- 52-week range $1.30–$4.85; today's close sits at 28% of that range, 52.8% below the 52-week high.
- That makes 6 straight losses.
Oct 13, 2026 — ADAG slides 10.2% to $2.46, a 6-month low, 5 down days in a row
- Closed at $2.46, -10.22% vs the prior close of $2.74. Day range $2.43–$2.73, opened at $2.73.
- Volume was 228.50K shares, 0.8x its 50-day average of 283.56K.
- Price is -28.6% vs its 50-day average ($3.44) and -27.2% vs its 200-day average ($3.38).
- 52-week range $1.30–$4.85; today's close sits at 33% of that range, 49.3% below the 52-week high.
- That makes 5 straight losses.
Oct 12, 2026 — ADAG dips 0.7% to $2.74, a 6-month low, 4 down days in a row
- Closed at $2.74, -0.72% vs the prior close of $2.76. Day range $2.68–$2.86, opened at $2.77.
- Volume was 216.50K shares, 0.8x its 50-day average of 282.28K.
- Price is -21.0% vs its 50-day average ($3.47) and -18.8% vs its 200-day average ($3.38).
- 52-week range $1.30–$4.85; today's close sits at 41% of that range, 43.5% below the 52-week high.
- That makes 4 straight losses.
Oct 9, 2026 — ADAG dips 0.7% to $2.76, a 6-month low on 6.5x normal volume
- Closed at $2.76, -0.72% vs the prior close of $2.78. Day range $2.62–$2.87, opened at $2.76.
- Volume was 1.65M shares, 6.5x its 50-day average of 251.93K — unusually heavy trading.
- Price is -20.8% vs its 50-day average ($3.49) and -18.1% vs its 200-day average ($3.37).
- 52-week range $1.30–$4.85; today's close sits at 41% of that range, 43.1% below the 52-week high.
- That makes 3 straight losses.
Oct 8, 2026 — ADAG dips 1.1% to $2.78, a 6-month low
- Closed at $2.78, -1.07% vs the prior close of $2.81. Day range $2.71–$3.10, opened at $2.80.
- Volume was 240.50K shares, 0.9x its 50-day average of 255.33K.
- Price is -20.7% vs its 50-day average ($3.51) and -17.4% vs its 200-day average ($3.37).
- 52-week range $1.30–$4.85; today's close sits at 42% of that range, 42.7% below the 52-week high.
Oct 7, 2026 — ADAG slides 4.1% to $2.81
- Closed at $2.81, -4.10% vs the prior close of $2.93. Day range $2.79–$3.10, opened at $2.90.
- Volume was 173.10K shares, 0.7x its 50-day average of 260.18K.
- Price is -20.3% vs its 50-day average ($3.53) and -16.4% vs its 200-day average ($3.36).
- 52-week range $1.30–$4.85; today's close sits at 43% of that range, 42.1% below the 52-week high.
Oct 6, 2026 — ADAG jumps 4.6% to $2.93
- Closed at $2.93, +4.64% vs the prior close of $2.80. Day range $2.82–$3.02, opened at $2.82.
- Volume was 213.50K shares, 0.8x its 50-day average of 259.90K.
- Price is -17.3% vs its 50-day average ($3.54) and -12.7% vs its 200-day average ($3.36).
- 52-week range $1.30–$4.85; today's close sits at 46% of that range, 39.6% below the 52-week high.
Oct 5, 2026 — ADAG dips 1.8% to $2.80, a 6-month low, 4 down days in a row
- Closed at $2.80, -1.75% vs the prior close of $2.85. Day range $2.67–$2.87, opened at $2.84.
- Volume was 325.70K shares, 1.3x its 50-day average of 255.93K.
- Price is -21.3% vs its 50-day average ($3.56) and -16.5% vs its 200-day average ($3.35).
- 52-week range $1.30–$4.85; today's close sits at 42% of that range, 42.3% below the 52-week high.
- That makes 4 straight losses.
Oct 2, 2026 — ADAG dips 2.7% to $2.85, a 6-month low, 3 down days in a row
- Closed at $2.85, -2.73% vs the prior close of $2.93. Day range $2.80–$3.00, opened at $2.96.
- Volume was 298.00K shares, 1.2x its 50-day average of 256.90K.
- Price is -20.0% vs its 50-day average ($3.56) and -14.9% vs its 200-day average ($3.35).
- 52-week range $1.30–$4.85; today's close sits at 44% of that range, 41.2% below the 52-week high.
- That makes 3 straight losses.
ADAG latest news & SEC filings
Every SEC filing by or about ADAG in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 25, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Tam Man Kin bought 2,000 shares at $3.00 (≈$6.00K) on Sep 23, 2026; now holds 12,000
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 25, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 22, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Luo Peter bought 20,290 shares at $3.15 (≈$63.98K) on Sep 16, 2026; now holds 88,535
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 10, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 9, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 19, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Do Cuong V bought 2,000 shares at $3.75 (≈$7.50K) on Aug 14, 2026
- Do Cuong V bought 2,000 shares at $3.75 (≈$7.50K) on Aug 14, 2026
- Do Cuong V bought 2,000 shares at $3.75 (≈$7.50K) on Aug 14, 2026
- Do Cuong V bought 2,000 shares at $3.75 (≈$7.50K) on Aug 14, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 12, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 6, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade ADAG
- How much it moves: over the last 20 sessions the average daily move was 4.19% (largest 14.2%). That is a volatile stock.
- Liquidity: about 388.77K shares (≈$800.87K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $2.06 vs a range of $1.30–$4.85 (21% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 20 open-market buys, 0 sales; latest: Man Kin Tam bought 2,000 shares on Sep 23, 2026.
- Latest filings: 6-K Sep 25, 2026; 6-K Sep 22, 2026; 6-K Sep 10, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
ADAG market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 2.40 | 2.40 | 2.01 | 2.06 | 379.60K |
| Oct 15, 2026 | 2.31 | 2.42 | 2.26 | 2.40 | 552.50K |
| Oct 14, 2026 | 2.35 | 2.50 | 2.25 | 2.29 | 898.90K |
| Oct 13, 2026 | 2.73 | 2.73 | 2.43 | 2.46 | 228.50K |
| Oct 12, 2026 | 2.77 | 2.86 | 2.68 | 2.74 | 216.50K |
| Oct 9, 2026 | 2.76 | 2.87 | 2.62 | 2.76 | 1.65M |
| Oct 8, 2026 | 2.80 | 3.10 | 2.71 | 2.78 | 240.50K |
| Oct 7, 2026 | 2.90 | 3.10 | 2.79 | 2.81 | 173.10K |
| Oct 6, 2026 | 2.82 | 3.02 | 2.82 | 2.93 | 213.50K |
| Oct 5, 2026 | 2.84 | 2.87 | 2.67 | 2.80 | 325.70K |
| Oct 2, 2026 | 2.96 | 3.00 | 2.80 | 2.85 | 298.00K |
| Oct 1, 2026 | 3.12 | 3.12 | 2.91 | 2.93 | 278.30K |
| Sep 30, 2026 | 3.18 | 3.35 | 3.00 | 3.20 | 254.30K |
| Sep 29, 2026 | 3.20 | 3.47 | 2.98 | 3.21 | 492.30K |
| Sep 28, 2026 | 2.94 | 3.21 | 2.87 | 3.20 | 528.40K |
| Sep 25, 2026 | 2.96 | 3.18 | 2.87 | 2.93 | 196.90K |
| Sep 24, 2026 | 2.94 | 3.01 | 2.81 | 2.98 | 317.00K |
| Sep 23, 2026 | 3.16 | 3.22 | 2.92 | 2.97 | 208.00K |
| Sep 22, 2026 | 3.31 | 3.34 | 3.21 | 3.23 | 226.30K |
| Sep 21, 2026 | 3.34 | 3.35 | 3.18 | 3.21 | 97.80K |
About Adagene
Adagene (ADAG) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in JIANGSU, China. State of incorporation: Cayman Islands. Fiscal year ends December 31. SEC CIK 1818838.
ADAG board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Andy Yiu Leung Cheung | Director | Aug 17, 2026 |
| Cuong V Do | Director | Aug 18, 2026 |
| Ulf Grawunder | Director | Aug 14, 2026 |
| Peter Luo | Chief Executive Officer | Sep 17, 2026 |
| Man Kin Tam | Chief Financial Officer | Sep 25, 2026 |
| Li Zhu | Director | Aug 17, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Mickael Yannick Chane-Du | Chief Strategy Officer | Mar 18, 2026 |
| Chunfang Gu | Executive Director of Finance | Mar 18, 2026 |
| Peter Luo | Chief Executive Officer | Sep 17, 2026 |
| Man Kin Tam | Chief Financial Officer | Sep 25, 2026 |
| Qinghai Zhao | Chief Manufacturing Officer | Mar 18, 2026 |
| Ling Zhou | ED of Human Resources | Mar 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 23, 2026 | Man Kin Tam | Buy | 2,000 | $3.00 |
| Sep 23, 2026 | Man Kin Tam | Buy | 2,000 | $3.00 |
| Sep 23, 2026 | Man Kin Tam | Buy | 2,000 | $3.00 |
| Sep 23, 2026 | Man Kin Tam | Buy | 2,000 | $3.00 |
| Sep 16, 2026 | Peter Luo | Buy | 20,290 | $3.15 |
| Sep 16, 2026 | Peter Luo | Buy | 20,290 | $3.15 |
| Sep 16, 2026 | Peter Luo | Buy | 20,290 | $3.15 |
| Sep 16, 2026 | Peter Luo | Buy | 20,290 | $3.15 |
| Aug 14, 2026 | Cuong V Do | Buy | 2,000 | $3.75 |
| Aug 14, 2026 | Cuong V Do | Buy | 2,000 | $3.75 |
| Aug 14, 2026 | Cuong V Do | Buy | 2,000 | $3.75 |
| Aug 14, 2026 | Cuong V Do | Buy | 2,000 | $3.75 |
| Aug 5, 2026 | Peter Luo | Buy | 279 | $3.65 |
| Aug 5, 2026 | Peter Luo | Buy | 279 | $3.65 |
| Aug 5, 2026 | Peter Luo | Buy | 279 | $3.65 |
ADAG financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
ADAG earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ADAG
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.